Literature DB >> 17335245

Bromopyrrole carboxamide biosynthetic products from the Caribbean sponge Agelas dispar.

Ivette C Piña1, Kimberly N White, Gustavo Cabrera, Eyleen Rivero, Phillip Crews.   

Abstract

Two new bromopyrrole alkaloids, dispyrin (6) and dibromoagelaspongin methyl ether (12), were isolated from the Caribbean sponge Agelas dispar, collected near the Venezuelan island La Blanquilla, and their structures were elucidated from spectroscopic data analysis. Dispyrin (6) contains a novel bromopyrrole tyramine motif that has no precedent in marine natural products chemistry and represents a notable variation from the oroidin class compounds consistently produced by species of Agelas in general. Compounds isolated from Caribbean Agelas species were found to possess a unique biogeographical bromination trend.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17335245     DOI: 10.1021/np0606042

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  4 in total

1.  A novel class of H3 antagonists derived from the natural product guided synthesis of unnatural analogs of the marine bromopyrrole alkaloid dispyrin.

Authors:  J Phillip Kennedy; P Jeffrey Conn; Craig W Lindsley
Journal:  Bioorg Med Chem Lett       Date:  2009-05-03       Impact factor: 2.823

2.  Bromopyrrole Alkaloids with the Inhibitory Effects against the Biofilm Formation of Gram Negative Bacteria.

Authors:  Jingyuan Sun; Jiru Wu; Bang An; Nicole J de Voogd; Wei Cheng; Wenhan Lin
Journal:  Mar Drugs       Date:  2018-01-02       Impact factor: 5.118

Review 3.  Secondary metabolites from marine sponges of the genus Agelas: a comprehensive update insight on structural diversity and bioactivity.

Authors:  Mei-Jun Chu; Meng Li; He Ma; Ping-Lin Li; Guo-Qiang Li
Journal:  RSC Adv       Date:  2022-03-09       Impact factor: 3.361

Review 4.  Bioactive Secondary Metabolites from the Marine Sponge Genus Agelas.

Authors:  Huawei Zhang; Menglian Dong; Jianwei Chen; Hong Wang; Karen Tenney; Phillip Crews
Journal:  Mar Drugs       Date:  2017-11-08       Impact factor: 5.118

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.